Skip to Content

Ampyra Side Effects

Generic Name: dalfampridine

Note: This document contains side effect information about dalfampridine. Some of the dosage forms listed on this page may not apply to the brand name Ampyra.

In Summary

Common side effects of Ampyra include: urinary tract infection. Other side effects include: equilibrium disturbance, insomnia, and nausea. See below for a comprehensive list of adverse effects.

For the Consumer

Applies to dalfampridine: oral tablet extended release

Along with its needed effects, dalfampridine (the active ingredient contained in Ampyra) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.

Check with your doctor immediately if any of the following side effects occur while taking dalfampridine:

More common
  • Bladder pain
  • bloody or cloudy urine
  • difficult, burning, or painful urination
  • frequent urge to urinate
  • lower back or side pain
Less common
  • Blurred vision
  • burning, crawling, itching, numbness, prickling, "pins and needles", or tingling feelings
  • difficulty controlling your bladder or bowels
  • difficulty walking
  • feeling sad or depressed
  • forgetful
  • muscle cramps
  • problems with swallowing
  • slurred speech
  • unusual tiredness or weakness
Incidence not known

Get emergency help immediately if any of the following symptoms of overdose occur while taking dalfampridine:

Symptoms of overdose
  • Confusion
  • epileptic seizure that will not stop
  • increased sweating
  • memory loss
  • reduced awareness
  • seizures
  • weakness

Some side effects of dalfampridine may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects. Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:

More common Less common

For Healthcare Professionals

Applies to dalfampridine: oral tablet extended release

Nervous system

Common (1% to 10%): Dizziness, headache, balance disorder, multiple sclerosis relapse, paresthesia, tremor
Uncommon (0.1% to 1%): Seizure, exacerbation of trigeminal neuralgia[Ref]

Gastrointestinal

Common (1% to 10%): Nausea, constipation, dyspepsia
Postmarketing reports: Vomiting[Ref]

Musculoskeletal

Common (1% to 10%): Back pain[Ref]

Respiratory

Common (1% to 10%): Nasopharyngitis, pharyngolaryngeal pain, dyspnea[Ref]

Genitourinary

Very common (10% or more): Urinary tract infection (12%)[Ref]

Hypersensitivity

Uncommon (0.1% to 1%): Anaphylaxis, angioedema, hypersensitivity[Ref]

Psychiatric

Common (1% to 10%): Insomnia, anxiety[Ref]

Other

Common (1% to 10%): Asthenia
Uncommon (0.1% to 1%): Chest discomfort[Ref]

Cardiovascular

Common (1% to 10%): Palpitations[Ref]

Dermatologic

Uncommon (0.1% to 1%): Rash, urticaria[Ref]

References

1. "Product Information. Ampyra (dalfampridine)." Acorda Therapeutics, Hawthorne, NY.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Some side effects may not be reported. You may report them to the FDA.

Medical Disclaimer

Hide